Digital Marketing Company for Sale

AliveCor Announces Strategic Additions to Executive Team

AliveCor Announces Strategic Additions to Executive Team
Written by publishing team

Mountain View, California.And January 11 2022 /PRNewswire/- AliveCorThe global leader in FDA-authorized electrocardiogram (ECG) technology today announced the addition of four new leaders to the company’s executive team: Vincent Balsamo As Executive Vice President of Global Sales, Dr. Archana Dubey As Chief Clinical Officer, Dr. Ben Green As Senior Vice President of Services, the Jessica Weinstein As Senior Vice President of Marketing.

“As we continue to expand into new markets and services, the additions of Vincent, Archana, Ben and Jessica to the team will help achieve our goal of becoming the number one provider of remote cardiac care for providers, creditors, employers and patients,” he said. Priya AbaniCEO of AliveCor.

Vincent Balsamo He has over 25 years of experience in healthcare and technology, and has led three acquisitions, two initial public offerings, and several project rounds. Previously he was Vice President of Sales overseeing the Marketing Cloud Payor business at Salesforce and has held leadership roles in telehealth, digital therapies and health at Cisco, IBM, Avizia (acquired by AmWell) and Propeller Health (acquired by Resmed). Balsamo joins AliveCor from Sequoia-backed AI Stealth, where he served as Director of Revenue and Interim Co-CEO. In this role, he oversaw business operations, managed strategic partnerships, and helped close a business 25 million dollars Strategic financing round, overseeing the company’s restructuring. Balsamo joined AliveCor at December 2021 And reports to Abani.

Doctor. Archana Dubey She has over 25 years of experience as a physician, executive, entrepreneur, and strategic advisor for her role at AliveCor. For more than a decade, she has provided clinical leadership for self-insured employers including Google, HP, and HPE, in addition to her work at Adj. Assistant Professor of Medicine at the University of Stanford University. Prior to AliveCor, Dr. Dube spent the past six years as Global Medical Director at HP, leading partnerships with payers and digital health companies to help improve employee engagement and health outcomes. In 2017, Dr. Dube founded Invent Health, a platform that connects venture capital funds, health systems and digital health solutions to give good ideas a chance to survive and expand from funding to adoption. Dr. Dube joined AliveCor in the first quarter of 2021 and reports to the Product Manager Alfred Wu.

Doctor. Ben Green He comes to AliveCor with 15 years of experience providing telehealth and home care. He spent the past four years at Amazon as the founding chief medical officer of Amazon’s first healthcare endeavor, AmazonCare, and later as Director of Healthcare Innovation for Global Benefits. Earlier, Dr. Green was the Regional Medical Director at Landmark Health and spent eight years in leadership and strategy positions at Carena, Inc. (acquired by Avizia/AmWell), a leading telemedicine company. Dr. Green joined AliveCor in the third quarter of 2021 and reports to the Chief Strategy Officer Sanjay Folletti.

Jessica Weinstein He joins AliveCor as a seasoned global marketing leader and brand builder with over 20 years of experience driving marketing initiatives to impact consumers’ lives and deliver meaningful business results. Throughout her career, Weinstein has worked on numerous joint ventures, acquisitions, and brand integrations; Launched dozens of successful new products; It has created award-winning campaigns. She has held various global leadership positions in consumer healthcare at Reckitt and GSK, managing portfolios 1 billion dollars. Weinstein joined AliveCor at November 2021 And reports to Abani.

To learn more about the AliveCor story and product presentation, visit alivecor.com.

About AliveCor
AliveCor, Inc. Transforming cardiac care using deep learning. The FDA-approved KardiaMobile is the world’s most clinically validated personalized ECG solution. KardiaMobile 6L provides immediate detection of atrial fibrillation, bradycardia, tachycardia, sinus rhythm with supraventricular endoscopy, sinus rhythm with premature ventricular contractions, sinus rhythm with wide QRS and normal heart rhythm on an electrocardiogram. Kardia is the first AI-enabled platform to help patients and clinicians early detect atrial fibrillation, the most common arrhythmia condition and one associated with a higher risk of stroke. The AliveCor Foundation platform allows third-party providers to simply manage the heart conditions of their patients and customers using state-of-the-art tools that provide easy front- and back-end integration of AliveCor technologies. AliveCor strictly protects its customers Data Security and Compliance Practices, achieving HIPAA compliance and SOC2 Type 1 and Type 2 certifications. AliveCor is a private company headquartered in Mountain View, California. “Consumer” or “personal” EKGs are EKGs available for direct sale to consumers. For more information visit alivecor.com.

SOURCE AliveCor, Inc.

.

About the author

publishing team